Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

GRACE bridGing gaps in caRdiAC health managEment

Coordinator
Universita Campus Bio Medico Di Roma, Italy
Runs
1 February 2025 to 31 July 2029
Status
Running
EU funding
€11.7m
Total cost
€19.2m
Partners
27 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101194778

What the project is doing

In the project's own words, from its summary on CORDIS.

The GRACE integrated solution aims to transform the healthcare ecosystem by providing essential knowledge and innovative public-private partnership for (1) reorganizing healthcare services (2) with embedded innovative technologies and tools, helping identifying and overcoming barriers and gaps that are now hindering CVD management, ensuring a seamless continuum of care and optimized care pathways. Our vision is that introducing effective health technology and interventions is economically, societally and environmentally sustainable if and only accompanied by a substantial healthcare service re-organization.

Accordingly, GRACE will focus on an end-to-end clinical pathway CVD, considering an holistic view of the patient and optimizing healthcare services leveraging on advanced technological solutions. GRACE intervention will be multifold aiming at: (1) guiding strategic policies, (2) drive market innovation, and (3) foster effective healthcare delivery practices in CVD, generating value for patients, healthcare workers and system.

GRACE will enable early and personalized interventions, fostering coordination of multidiscipline healthcare teams, triggering more intense and person-specific management using innovative technologies, AI and digital solutions for early detection of red flags, promoting patient empowerment, while comprehensively containing CVD risk factors and burden. A multidisciplinary consortium of experienced and competitive partners will implement this vision and implement the proposed solution in a novel multidiscipline manner.

Who is involved

OrganisationCityCountryRole
Universita Campus Bio Medico Di RomaRomaItalyCoordinator
Udg AllianceLausanneSwitzerlandAssociatedpartner
Universitatsklinikum BonnBonnGermanyParticipant
Bridg OuTallinEstoniaParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
Active Ageing AssociationPaternaSpainParticipant
Astrazeneca Farmaceutica Spain, S.aMadridSpainParticipant
Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (f.s.p.)MadridSpainParticipant
Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental-Alejandro OteroGranadaSpainParticipant
Happy Mondays Communication SLMadridSpainParticipant
Institut Catala De La SalutBarcelonaSpainParticipant
Medtronic Iberica SAMadridSpainParticipant
Outcomes'10 SLCastellón de la PlanaSpainParticipant
Predictby Research and Consulting S.l.BarcelonaSpainParticipant
Servicio Madrileno De SaludMadridSpainParticipant
Centre Hospitalier Universitaire De RennesRennes Cedex 9FranceParticipant
Medtronic FranceBoulogneFranceParticipant
Philips Medical Systems Technologies LtdHaifaIsraelParticipant
Dedalus Italia S.p.a.FirenzeItalyParticipant
Fondazione Policlinico Universitario Agostino Gemelli IrccsRomaItalyParticipant
Fondazione Policlinico Universitario Campus Bio MedicoRomaItalyParticipant
Human Factor & Innovation SRLMilanoItalyParticipant
Samsung ElectronicsSuwonSouth KoreaAssociatedpartner
Philips Medical Systems Nederland BVBestNetherlandsParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Wavy Assistant BVGroningenNetherlandsParticipant
Samsung Electronics (UK) LimitedChertsey - SurreyUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI